Yasuyuki Deguchi

The S 1 P receptor modulator FTY 720 prevents the development of experimental colitis in mice

O. Inatomi, A. Andoh, S. Bamba, 2022 .

Suppression of Inflammatory Cytokine Secretion by Granulocyte/Monocyte Adsorptive Apheresis in Active Ulcerative Colitis

K. Mitsuyama, O. Inatomi, A. Andoh, 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

system, and cyclosporine A augments its in vivo activity leukemia cells in the central nervous + suppresses the growth of Ph INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor,

S. Kimura, J. Kuroda, S. Masuda, 2010 .

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity.

S. Kimura, J. Kuroda, S. Masuda, 2007, Blood.

Curcumin Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental Colitis

O. Inatomi, A. Andoh, S. Bamba, 2007, Digestive Diseases and Sciences.

Leukocytapheresis Therapy Modulates Circulating T cell Subsets in Patients With Ulcerative Colitis

K. Mitsuyama, O. Inatomi, A. Andoh, 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease.

O. Inatomi, A. Andoh, S. Bamba, 2006, Oncology reports.

Interleukin-17 augments tumor necrosis factor-α-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts

A. Takayanagi, N. Shimizu, O. Inatomi, 2005, Journal of Gastroenterology.

Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts.

A. Takayanagi, N. Shimizu, O. Inatomi, 2005, Gastroenterology.

Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines.

Tomoko Niwa, Yoshihide Fujiyama, Eishi Ashihara, 2007, Leukemia research.

Development of dextran sulfate sodium-induced colitis is aggravated in mice genetically deficient for complement C5.

O. Inatomi, A. Andoh, Y. Fujiyama, 2005, International journal of molecular medicine.

The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.

O. Inatomi, A. Andoh, S. Bamba, 2006, Oncology reports.

INNO-406, a novel BCR-ABL/Lyn dual tyrosine kinase inhibitor, suppresses the growth of Ph+ leukemia cells in the central nervous system, and cyclosporine A augments its in vivo activity.

S. Kimura, J. Kuroda, S. Masuda, 2007, Blood.